Opposing roles of eosinophils in cancer
Open accessThe DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Abstract
Eosinophils are a subset of granulocytes mostly known for their ability to combat parasites and induce allergy. Although they were described to be related to cancer more than 100 years ago, their role in tumors is still undefined. Recent observations revealed that they display regulatory functions towards other immune cell subsets in the tumor microenvironment or direct cytotoxic functions against tumor cells, leading to either antitumor or protumor effects. This paradoxical role of eosinophils was suggested to be dependent on the different factors in the TME. In addition, the clinical relevance of these cells has been recently addressed. In most cases, the accumulation of eosinophils both in the tumor tissue, called tumor-associated tissue eosinophilia, and in the peripheral blood were reported to be prognostic markers for a better outcome of cancer patients. In immunotherapy of cancer, particularly in therapy with immune checkpoint inhibitors, eosinophils were even shown to be a potential predictive marker for a beneficial clinical response. A better understanding of their role in cancer progression will help to establish them as prognostic and predictive markers and to design strategies for targeting eosinophils.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Considering that eosinophils can have a role in the response against cancer,17–20 an elevated AEC might be a marker of effectiveness in some patients.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eosinophils Sustain Adipose Alternatively Activated Macrophages Associated with Glucose Homeostasis
Wu, D., Molofsky, A. B., Liang, H.-E., Ricardo-Gonzalez, R. R., Jouihan, H. A., Bando, J. K., Chawla, A., & Locksley, R. M. (2011) · Science · doi:10.1126/science.1201475 · Cited by 1,376
Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
Nair, P., Pizzichini, M. M. M., Kjarsgaard, M., Inman, M. D., Efthimiadis, A., Pizzichini, E., Hargreave, F. E., & O'Byrne, P. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805435 · Cited by 1,356
Rothenberg, M. E., & Hogan, S. P. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090720 · Cited by 1,356
Frumento, G., Rotondo, R., Tonetti, M., Damonte, G., Benatti, U., & Ferrara, G. B. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020121 · Cited by 1,133
Type 2 innate lymphoid cells control eosinophil homeostasis
Nussbaum, J. C., Van Dyken, S. J., von Moltke, J., Cheng, L. E., Mohapatra, A., Molofsky, A. B., Thornton, E. E., Krummel, M. F., Chawla, A., Liang, H.-E., et al. (2013) · Nature · doi:10.1038/nature12526 · Cited by 1,068
Eosinophils: changing perspectives in health and disease
Rosenberg, H. F., Dyer, K. D., & Foster, P. S. (2013) · Nature Reviews Immunology · doi:10.1038/nri3341 · Cited by 989
Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense
Yousefi, S., Gold, J. A., Andina, N., Lee, J. J., Kelly, A. M., Kozlowski, E., Schmid, I., Straumann, A., Reichenbach, J., Gleich, G. J., et al. (2008) · Nature Medicine · doi:10.1038/nm.1855 · Cited by 967
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Labani-Motlagh, A., Ashja-Mahdavi, M., & Loskog, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00940 · Cited by 751
Inflammation and necrosis promote tumour growth
Vakkila, J., & Lotze, M. T. (2004) · Nature Reviews Immunology · doi:10.1038/nri1415 · Cited by 690
Clutterbuck, E., Hirst, E., & Sanderson, C. (1989) · Blood · doi:10.1182/blood.v73.6.1504.1504 · Cited by 687
Research works printed but not linked: 1
- Feldbausch F (1900) The occurrence of eosinophilic leukocytes in tumours. Archiv Fur Pathologische Anatomie Physiologie Fur Klinische Medicin 161(1):1–18
Cited by
Items 101–127 of 127
Saravani, S., Kadeh, H., Amin, M. T., & Ghavidel, N. (2022) · International Journal of Cancer Management · doi:10.5812/ijcm-117673 · Cited by 1
Gaitanis, G., Ganiatsa, A., Vartholomatos, G., Seretis, K. G., & Bassukas, I. D. (2024) · JEADV Clinical Practice · doi:10.1002/jvc2.573 · Cited by 1
Xing, Z., Lei, H., Jiang, Y., Wu, S., Zang, Q., Qiu, S., Xie, E., Wang, Y., Gao, N., Yeo, Y. H., et al. (2025) · Phenomics · doi:10.1007/s43657-025-00229-6 · Cited by 4
“Previous studies have revealed that eosinophils (Simon et al. 2019), group 2 innate lymphoid cells (Wu et al. 2022), IgE (Luiten et al. 1996; Schmidt et al. 1976; Vecchi and Lis-soni 1995), and signal transducer and activator of transcription 6 (Karpathiou et al. 2021) were associated with both…”
IL-1 family members as regulators of lymphoid type-2 immunity in cancer
Roma, S., Colombo, F., Monte, L. B. D., & Protti, M. P. (2025) · Seminars in Immunology · doi:10.1016/j.smim.2025.102005 · Cited by 2
Celestial Insights: Unraveling the Role of miR-3682-3p in Hepatocellular Carcinoma
Miao, P.-D., Li, Y., & Jiang, Y. (2024) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000690 · Cited by 1
Unexpected Multiple Gastrointestinal Cancers in a Patient with Chronic Eosinophilia: A Case Report
Xie, W., Hong, B., Hu, C., Luan, F., & Gong, W. (2024) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-024-01134-3 · Cited by 1
“Eosinophils have been implicated as a favorable prognosis in the majority of cases [3].”
Antibiotic Allergy and Blood Eosinophils Percent Could Be Prognostic Indicators of GliomaPreprint
Cao, L., Lv, Z., Wang, W., Li, X., Shi, J., Liang, H., Zhang, Y., & Hu, F. (2021) · Research Square · doi:10.21203/rs.3.rs-148347/v1
Eosinophils, Mast Cells and Basophils
Puzzovio, P. G., & Levi‐Schaffer, F. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00051-7
Agus, N. P., Delyuzar, Lubis, M. N. D., Soekimin, S., & Lukito, J. S. (2021) · International Journal of Research Publications · doi:10.47119/ijrp100811720212110
“16,17 However, the controversies of the prognostic value reported might also be influenced by several other factors, and this was not yet known.”
(2022) · Elsevier eBooks · doi:10.1016/b978-0-12-813755-0.09990-1
Antibiotic allergy and blood eosinophils percent could be prognostic indicators of gliomaPreprint
SUN, Q., Cao, L., WANG, H., Wang, W., Li, X., Shi, J. C., Liang, H., Zhang, Y., & Lv, Z. (2022) · Research Square · doi:10.21203/rs.3.rs-148347/v2
MECHANIZMY PROWADZĄCE DO ANGIOGEGNEZY W NOWOTWORACH
Tchorzewska, M., Kowalik, M., Kuliś, A., & Olejarz, W. (2019) · Prospects in Pharmaceutical Sciences · doi:10.56782/pps.20
Zhu, Z., Peng, L., Luo, H., Jiang, Y., Yang, M., Gu, H., & Wang, Y. (2022) · medRxiv · doi:10.1101/2022.11.04.22281961
“B cells, multiple T cells except Tregs, dendritic cells and eosinophils have been shown to favor the survival of LUAD patients [22].”
BackgroundDai, P., Wei, Y., Xiong, L., Zhou, X., Zhou, X., Xu, M., Zhao, J., & Tang, H. (2023) · Future Oncology · doi:10.2217/fon-2022-0674
SLC35G2 as a Prognostic Biomarker in Hepatocellular carcinoma and Its Correlation with ImmunityPreprint
Meng, Y., Yuan, L., Huang, X., Li, Y., Fu, S., & Peng, X. (2023) · Research Square · doi:10.21203/rs.3.rs-2902000/v1
Rugambwa, T. K. (2023) · Gastroenterology Medicine & Research · doi:10.31031/gmr.2023.07.000665
Hypereosinophilia with Renal Injury Caused by Immune Checkpoint Inhibitor
Schiappacasse, G. (2023) · Journal on oncology · doi:10.52768/2692-563x/1109
Zhang, S., Long, J., Hu, Z., Huang, W., Hu, W., & Zeng, Z. (2024) · Springer eBooks · doi:10.1007/978-981-97-6246-0_3
Ho, C. Y. R., Cheung, K. M., Chow, C. H. J., & Cheung, G. T. C. (2025) · Cureus · doi:10.7759/cureus.94131
“Eosinophils also aid in the activation of dendritic cells and recruitment of T cells, suggesting a pivotal role in tumour surveillance and rejection to achieve a better disease control in response to IO [31-35].”
Caractérisation transcriptomique des cellules lymphoïdes innées
Crinier, A. (2020) · theses.fr (ABES) · doi:10.70675/850e38aazc227z4187z9c41z07c47cac00d9
HVEM : une nouvelle cible prometteuse d'immunothérapie anti-cancéreuse
Demerle, C. (2023) · theses.fr (ABES) · doi:10.70675/9e290f7fz176bz4249zba2aze5e67eeff324
Li, L., Wang, J.-M., Xu, J.-C., Su, Q.-H., Shu, R., Zhou, X.-B., Zhuang, J.-W., & Shan, Z. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-05857-y
Eosinophils and Basophils in Breast Cancer, the Neglected Players?
Garay-Canales, C. A., Aragón-Franco, R., Rodríguez-Santiago, Y., Ruiz-Antonio, D. L., Ríos-Avila, M. D. S., Zavala-López, C. A., Castro, K. E. N., & Morales‐Montor, J. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1015770
Chen, W., & Ding, G.-M. (2026) · Medicine · doi:10.1097/md.0000000000049256
Zhang, L., Wang, T.-Y., He, X.-S., Zhou, Q., Lv, H., Lai, R.-T., Jiang, Z., & Jiang, F.-F. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1853027
LeVee, A. A., Jacob, S. L., Fisch, S. C., Face, C., Chengappa, M., Chaudhry, S., Baclig, N. V., Soliman, A., Ruel, N. H., Wong, M. H., et al. (2026) · The Breast · doi:10.1016/j.breast.2026.104941
“Eosinophils may potentiate the risk of irAE through its role in adaptive immunity, whereby eosinophils contribute to antigen presentation to T cells and recruitment of other leukocytes [50].”
CCL11 as a cancer target: molecular role and the mechanisms for potential therapeutic intervention
He, Z., & Wang, M. (2026) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2026.2755122
Metadata
- Authors
- Simon, S. C. S., Utikal, J., & Umansky, V.
- Affiliations
- German Cancer Research Center (DE)
- Corresponding author
- Umansky, Viktor
- Venue
- Cancer Immunology, Immunotherapy
- Published
- 2018-10-09
- Volume
- 68
- Issue
- 5
- Pages
- 823-833
- ISSN
- 0340-7004 (ISSN-L)
- 1432-0851
- PMC
- PMC11028063
- OpenAlex
- W2896948312
- Semantic Scholar
- 51d1f88740bcf0f7ea77a0ef42febece0d7266cd
- Cited by
- 128
- References
- 110
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 17 · 2023: 14 · 2022: 23 · 2021: 30 · 2020: 21 · 2019: 9
- FWCI
- 6.44
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cancer Immunology Immunotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (RTG2099)
- Deutsches Krebsforschungszentrum (CA181)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- eosinophils, tumor microenvironment, antitumor immunity, tumor-associated tissue eosinophilia, prognostic factors, predictive biomarkers, immune checkpoint inhibitors, cancer immunotherapy, eosinophil-targeted therapy, granulocytes
- MeSH terms
- Cytotoxicity, Immunologic, Eosinophils, Humans, Hypersensitivity, Immunotherapy, Neoplasms, Parasitic Diseases, Prognosis, Biomarkers, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.